Antiplatelet drugs and risk of subarachnoid hemorrhage: A population-based case-control study

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 7, 2010, Pages 1468-1474

  Schmidt, M ^a   Johansen, M B ^a   Lash, T L ^a,b   Christiansen, C F ^a   Christensen, S ^a   Sorensen H T ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acetylsalicylic acid; Antiplatelet drugs; Clopidogrel; Dipyridamole; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; COMORBIDITY; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; ASPIRIN; CASE-CONTROL STUDIES; DENMARK; DIPYRIDAMOLE; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK; SUBARACHNOID HEMORRHAGE; TICLOPIDINE; TIME FACTORS; YOUNG ADULT;

EID: 77955015411     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03856.x     Document Type: Article

References (46)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86.
2. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005, 352:1179-89.
3. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002, 288:2411-20.
4. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494-502.
5. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006, 367:1665-73.
6. Vallurupalli NG, Goldhaber SZ. Gastrointestinal complications of dual antiplatelet therapy. Circulation 2006, 113:e655-8.
7. Serebruany VL, Malinin A, Eisert R, Sane D. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol 2004, 75:40-7.
8. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007, 369:306-18.
9. Gaist D, Vaeth M, Tsiropoulos I, Christensen K, Corder E, Olsen J, Sorensen HT. Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark. BMJ 2000, 320:141-5.
10. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998, 29:251-6.
11. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005, 36:2773-80.
12. Frank L. Epidemiology. When an entire country is a cohort. Science 2000, 287:2398-9.
13. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-8.
14. Ingeman A, Pedersen L, Hundborg HH, Petersen P, Zielke S, Mainz J, Bartels P, Johnsen SP. Quality of care and mortality among patients with stroke: a nationwide follow-up study. Med Care 2008, 46:63-9.
15. Johnsen SP, Pedersen L, Friis S, Blot WJ, McLaughlin JK, Olsen JH, Sørensen HT. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003, 34:387-91.
16. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006, 53:441-9.
17. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992, 135:1019-28.
18. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44:445-8.
19. Available drugs and package sizes on the Danish drug market. http://www.lmk.dk, ; Accessed 4 June 2010
20. Bowman AJ, Chen CP, Ford GA. Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol 1994, 38:199-204.
21. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003, 41:1281-6.
22. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ. The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002, 20:1035-43.
23. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003, 23:729-36.
24. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998, 97:576-80.
25. Khurana VG, Meissner I, Sohni YR, Bamlet WR, McClelland RL, Cunningham JM, Meyer FB. The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005, 102:526-31.
26. Johnsen SP, Sørensen HT, Mellemkjoer LF, Blot WJ, Nielsen GL, McLaughlin JK, Olsen JH. Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thromb Haemost 2001, 86:563-8.
27. Mellemkjaer L, Blot WJ, Sorensen HT, Thomassen L, McLaughlin JK, Nielsen GL, Olsen JH. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002, 53:173-81.
28. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006, 119:113-16.
29. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003, 158:915-20.
30. Rothman KJ, Greenland S, Lash TL. Case-control studies. Modern Epidemiology 2008, 124-5. Rothman KJ, Greenland S, Lash TL. eds, 3th edn, Philadelphia, PA, Lippincott Williams & Wilkins
31. Rothman KJ, Greenland S, Lash TL. Selecting confounders for control. Modern Epidemiology 2008, 261-4. Rothman KJ, Greenland S, Lash TL. eds, 3th edn, Philadelphia, PA, Lippincott Williams & Wilkins
32. Gender-specific smoking prevalence in Denmark. 2003, http://www.nationmaster.com/graph/hea_smo_pre_mal_of_adu-health-smoking-prevalence-males-adults&date=2003, World Development Indicators Database.
33. State-specific prevalence of cigarette smoking among adults in Maryland, US, 2002. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5253a1.htm
34. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 2009, 169:788-96.
35. Lash TL, Fox MP, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. 2009, 138-42. New York, Springer
36. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329-39.
37. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005, 36:1588-93.
38. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:331-7.
39. Gamboa A, Abraham R, Diedrich A, Shibao C, Paranjape SY, Farley G, Biaggioni I. Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. Stroke 2005, 36:2170-5.
40. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007, 78:1365-72.
41. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50:1413-18.
42. Sørensen HT. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 1997, 10:1-22.
43. Brenner H, Savitz DA. The effects of sensitivity and specificity of case selection on validity, sample size, precision, and power in hospital-based case-control studies. Am J Epidemiol 1990, 132:181-92.
44. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-35.
45. Mose H, Larsen M, Riis A, Johnsen SP, Thomsen RW, Sørensen HT. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission. Am J Geriatr Pharmacother 2006, 4:244-50.
46. Sørensen HT, Mellemkjaer LF, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000, 95:2218-24.